Cutaneous Adverse Events During Treatment of Chronic Inflammatory Rheumatic Conditions With Tumor Necrosis Factor Antagonists: Study Using the Spanish Registry of Adverse Events of Biological Therapies in Rheumatic Diseases-Reference-Cited by-同舟云学术

Cutaneous Adverse Events During Treatment of Chronic Inflammatory Rheumatic Conditions With Tumor Necrosis Factor Antagonists: Study Using the Spanish Registry of Adverse Events of Biological Therapies in Rheumatic Diseases

Published:2013-11-27 Issue:12 Volume:65 Page:2024-2031
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Hernández Mª Victoria¹,Sanmartí Raimon¹,Cañete Juan D.¹,Descalzo Miguel A.²,Alsina Mercè¹,Carmona Loreto³,Gomez-Reino Juan J.⁴,

Affiliation:

1. Hospital Clínic; Barcelona Spain

2. Spanish Society of Rheumatology; Madrid Spain

3. Universidad Camilo José Cela; Madrid Spain

4. Hospital Clínico Universitario and Universidad de Santiago de Compostela; Santiago de Compostela Spain

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.22096/fullpdf

Reference50 articles.

1. New advances in the management of juvenile idiopathic arthritis-2: the era of biologicals;Beresford;Arch Dis Child Educ Pract Ed,2009

2. Biological therapies in the spondyloarthritides: the current state;Braun;Rheumatology (Oxford),2004

3. New drugs for rheumatoid arthritis;Olsen;N Engl J Med,2004

4. TNF-α antagonists beyond approved indications: stories of success and prospects for the future;Karampetsou;QJM,2010

5. Infections in patients with rheumatic diseases treated with TNF antagonists;Perez-Zafrilla;Curr Pharm Biotechnol,2012

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradoxical psoriasis induced by IL-17 inhibitors: a case series of patients with axial spondyloarthritis and a systematic literature review;Rheumatology International;2024-06-25

2. Safety and Effectiveness of SB2 (Infliximab Biosimilar) in Adult Patients with Immune-Mediated Inflammatory Diseases: A Post-Marketing Surveillance in Korea;Advances in Therapy;2023-01-10

3. Paradoxical reactions to biologicals in chronic inflammatory systemic diseases;Deutsches Ärzteblatt international;2022-02-11

4. Biologic and targeted therapeutics in vitiligo;Journal of Cosmetic Dermatology;2022-02-09

5. YouTube for information about side effects of biologic therapy: A social media analysis;International Journal of Rheumatic Diseases;2020-10-22